Navigation Links
Investor Group Commends Jim Merselis for Joining Trinity Biotech's Board of Directors & Announces Conference Call Invitation
Date:2/12/2009

KANSAS CITY, Mo., Feb. 12 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, is delighted that Jim Merselis has joined the company's board of directors. In addition to expressing support for Mr. Merselis, the group has scheduled a conference call regarding important shareholder developments for 12:00 pm ET (9:00 am PT) on Tuesday, February 17, 2009.

All those interested in participating in the call should dial 888 300 5688 and reference Conference ID 85881585.

Commenting on the news, Mr. Reidy stated, "We are pleased Jim has agreed to serve, bringing the total of independent directors to two. While Jim's agreement to join as part of our broader effort is honorable, we continue our call to action for true board oversight and management accountability. We look forward to Jim remaining as part of our new board immediately following the pending action to remove and replace the current board."

Commenting on the campaign and pending conference call, Mr. Reidy stated, "Much progress has been made that we look forward to sharing with our fellow shareholders, and we remain committed to our goals to effect the changes needed to unlock shareholder value and provide the level of transparency we have continued to advocate."

Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Champions Biotechnology, Inc.s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference
2. Genaera to Present at BIO CEO & Investor Conference
3. Rigel to Present at BIO CEO & Investor Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
7. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
8. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
9. SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009
10. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: